282 related articles for article (PubMed ID: 12218592)
21. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
22. Testicular tumors in children.
Ciftci AO; Bingöl-Koloğlu M; Senocak ME; Tanyel FC; Büyükpamukçu M; Büyükpamukçu N
J Pediatr Surg; 2001 Dec; 36(12):1796-801. PubMed ID: 11733909
[TBL] [Abstract][Full Text] [Related]
23. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis.
Amato RJ; Ro JY; Ayala AG; Swanson DA
Urology; 2004 Jan; 63(1):144-8; discussion 148-9. PubMed ID: 14751368
[TBL] [Abstract][Full Text] [Related]
24. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
Tarrant WP; Czerniak BA; Guo CC
Hum Pathol; 2013 Oct; 44(10):2220-6. PubMed ID: 23856516
[TBL] [Abstract][Full Text] [Related]
25. Early clinical stages of nonseminomatous testis cancer. Evaluation of the primary treatment and follow-up procedures of the SWENOTECA project.
Klepp O; Olsson AM; Ous S; Nilsson S; Høisaether PA; Tveter K
Scand J Urol Nephrol; 1991; 25(3):179-90. PubMed ID: 1658924
[TBL] [Abstract][Full Text] [Related]
26. Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testis.
Pizzocaro G; Nicolai N; Salvioni R
World J Urol; 1994; 12(3):113-9. PubMed ID: 7524920
[TBL] [Abstract][Full Text] [Related]
27. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
28. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
Peterson M; Beck S; Bihrle R; Einhorn L; Foster R
BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258
[TBL] [Abstract][Full Text] [Related]
29. Clinical behavior and a contemporary management algorithm for prepubertal testis tumors: a summary of the Prepubertal Testis Tumor Registry.
Ross JH; Rybicki L; Kay R
J Urol; 2002 Oct; 168(4 Pt 2):1675-8; discussion 1678-9. PubMed ID: 12352332
[TBL] [Abstract][Full Text] [Related]
30. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
31. Treatment of a stage I testicular yolk sac tumor with vascular invasion.
Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M; Nagashima K; Hirato J
Acta Paediatr Jpn; 1995 Aug; 37(4):537-40. PubMed ID: 7572162
[TBL] [Abstract][Full Text] [Related]
32. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
33. Treatment of a population based sample of men diagnosed with testicular cancer in the United States.
Osswald M; Harlan LC; Penson D; Stevens JL; Clegg LX
Urol Oncol; 2009; 27(6):604-10. PubMed ID: 18799329
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
35. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.
Spermon JR; Roeleveld TA; van der Poel HG; Hulsbergen-van de Kaa CA; Ten Bokkel Huinink WW; van de Vijver M; Witjes JA; Horenblas S
Urology; 2002 Jun; 59(6):923-9. PubMed ID: 12031382
[TBL] [Abstract][Full Text] [Related]
36. Primary chemotherapy for clinical stage II nonseminomatous germ cell tumors of the testis: a follow-up of 50 patients.
Logothetis CJ; Swanson DA; Dexeus F; Chong C; Ogden S; Ayala AG; von Eschenbach AC; Johnson DE; Samuels ML
J Clin Oncol; 1987 Jun; 5(6):906-11. PubMed ID: 2438389
[TBL] [Abstract][Full Text] [Related]
37. Testicular yolk sac tumors in children: a review of 61 patients over 19 years.
Wei Y; Wu S; Lin T; He D; Li X; Liu J; Liu X; Hua Y; Lu P; Wei G
World J Surg Oncol; 2014 Dec; 12():400. PubMed ID: 25547829
[TBL] [Abstract][Full Text] [Related]
38. [Study of twenty-three cases of pediatric testicular tumors].
Sano K; Nakaigawa N; Terashima K
Hinyokika Kiyo; 1996 Feb; 42(2):101-4. PubMed ID: 8712082
[TBL] [Abstract][Full Text] [Related]
39. Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.
Donohue JP; Thornhill JA; Foster RS; Rowland RG; Bihrle R
World J Urol; 1994; 12(4):170-6; discussion 177. PubMed ID: 7820136
[TBL] [Abstract][Full Text] [Related]
40. [Clinical characterization of testicular yolk sac tumor in children and adults].
Yu SL; Luo BJ; Zhai TY; Zhou NC; Jin ZB; Jia ZK; Yang JJ; Gu CH
Zhonghua Nan Ke Xue; 2019 Feb; 25(2):144-149. PubMed ID: 32216201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
